Press Releases
Press Releases
Dyax Corp. Launches Hereditary Angioedema Attack Tracker™, a Free iPhone Application for HAE Patients
Dyax Corp.today announced the launch of a free smartphone application for the iPhone – HAE Attack Tracker™. This application allows HAE patients to keep detailed records of their disease related information, including emergency and physician contacts as well...
Press Releases
BioRx Affirms Strong Supply of C1 Esterase Inhibitor Product
In response to reports of a shortage of one C1 esterase inhibitor product on the market, BioRx affirmed today that its supply of Berinert® remains strong and can immediately accommodate increased demand. The statement was in response to...
Press Releases
Emerging Biopharmaceutical Markets to Witness Exponential Growth
IMARC Group, one of the world‘s leading research and advisory firms, finds in its new report “Global Biopharmaceutical Market Report & Forecast 2010-2015” that driven by a huge patient pool, rapid economic growth and improving intellectual property rights,...
Press Releases
Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor
Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies, today announced the addition of George Demetri, M.D., as a clinical advisor and member of the scientific advisory board....
Press Releases
NeuroLogica Corporation Announces Partnership with MEYTEC GmbH
NeuroLogica Corporation and German based MEYTEC GmbH announced today the development of the world’s first comprehensive mobile stroke ambulance. Stroke-Emergency-Mobile, VIMED® STEMO, combines MEYTEC’s cutting-edge telemedicine solutions with NeuroLogica’s state of the art portable CT scanner, CereTomTM. ...
Press Releases
Baron and Budd Seeks to Help Women Harmed by YAZ, Yasmin, Beyaz and Ocella0
Baron and Budd, a national law firm dedicated to Protecting What’s Right, is stepping up to help women who have suffered serious health issues from the oral contraceptives YAZ, Yasmin, Beyaz and Ocella. Bayer,...
Press Releases
RBCC Target’s Brain Injury Treatment Awareness Campaign Reaches Milestone
Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp., today announced the collaboration of its latest target, Amarantus BioSciences, Inc., with Brewer Sports International to increase awareness about new medical therapies in development to effectively treat traumatic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read